CCR4 and neoplasm: We next examined the cytokine profiles of tumor-infiltrating lymphocytes following ex vivo stimulation, and found that T cells in the CCR4 antagonist-treated group secreted significantly higher amounts of IFN-γ, IL-2, and TNF-α than T cells in the control groups (P < 0.05 for each) (Figure 6E).